The researchers wanted to know if standard cytisine treatment for 25 days was at least as effective for smoking cessation as standard varenicline treatment for 84 days.
The review authors sought to elucidate the neurological harms of methamphetamine, which are well-documented but poorly understood.
Study data published in PLoS One suggest that gender minority (GM) adolescents may engage in substance use more frequently than their peers.
If immediate-release and extended-release formulations of buprenorphine are similarly efficacious to treat opioid use disorder, is one superior?
For the 12-month period ending in May 2020, the CDC reported 81,000 drug overdose deaths — the most ever recorded in a 12-month period in the United States. We interviewed Danielle F. Haley, MPH, PhD, assistant professor in the department of community health sciences at the Boston University School of Public Health about COVID-19 and the rates of substance abuse and overdose cases.
Dr Ben Locwin spoke to Dr Joshua Gear about the impact COVID-19 has had on our collective mental health, how we’re doing with regard to coping with the crisis, substance abuse, and what’s next.
The unapproved and misbranded opioids, which include tramadol and oxycodone, are being sold without a prescription.
Behavioral management of chronic pain may improve addiction treatment outcomes.
Researchers believe traffic fatalities may have increased in Colorado due to the state’s cannabis tourism industry, which is not as robust in Washington State.
Healthcare professionals see the benefits of prescribing cannabis therapies but report significant knowledge gaps in both recreational and medical cannabis.
